2023
P81 Investigating the relationship between green and blue spaces on maternal health and birth outcomes in Wales and Merseyside: a study protocol (Conference Paper)
Khalaf, R. K. S., Rodgers, S., Kolamunnage-Dona, R., & Wheeler, B. (2023). P81 Investigating the relationship between green and blue spaces on maternal health and birth outcomes in Wales and Merseyside: a study protocol. In SSM Annual Scientific Meeting. BMJ Publishing Group Ltd. doi:10.1136/jech-2023-ssmabstracts.184DOI: 10.1136/jech-2023-ssmabstracts.184
2022
Darlow, C. A., McEntee, L., Johnson, A., Farrington, N., Unsworth, J., Jimenez-Valverde, A., . . . Hope, W. (2022). Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77(12), 3349-3357. doi:10.1093/jac/dkac323DOI: 10.1093/jac/dkac323
Darlow, C., Farrington, N., McEntee, L., Johnson, A., Unsworth, J., Jimenez-Valverde, A., . . . Hope, W. (2022). 30 Determining a potential alternative empirical antibiotic regimen for the treatment of neonatal sepsis in low- and middle-income settings using pre-clinical in vitro techniques. Clinical Infection in Practice, 15, 100191. doi:10.1016/j.clinpr.2022.100191DOI: 10.1016/j.clinpr.2022.100191
Asiimwe, I. G., Pushpakom, S. P., Turner, R. M., Kolamunnage-Dona, R., Jorgensen, A. L., & Pirmohamed, M. (2022). Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-analysis of randomized controlled trials. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 88(8), 3577-3599. doi:10.1111/bcp.15331DOI: 10.1111/bcp.15331
Thygesen, J. H., Tomlinson, C., Hollings, S., Mizani, M. A., Handy, A., Akbari, A., . . . Longitudinal Health and Wellbeing COVID-19 National Core Study and the CVD-COVID-UK/COVID-IMPACT Consortium. (2022). COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records.. The Lancet. Digital health, 4(7), e542-e557. doi:10.1016/s2589-7500(22)00091-7DOI: 10.1016/s2589-7500(22)00091-7
Kolamunnage-Dona, R., & Johnson, P. (2022). Sorafenib is associated with reduced tumour growth rate and liver function deterioration in HCV-induced hepatocellular carcinoma. Journal of Hepatology.
Millward, C. P., Doherty, J. A., Mustafa, M. A., Humphries, T. J., Islim, A. I., Richardson, G. E., . . . McMahon, C. J. (2022). Cranioplasty with hydroxyapatite or acrylic is associated with a reduced risk of all-cause and infection-associated explantation. BRITISH JOURNAL OF NEUROSURGERY, 36(3), 385-393. doi:10.1080/02688697.2022.2077311DOI: 10.1080/02688697.2022.2077311
Darlow, C. A., Farrington, N., Johnson, A., McEntee, L., Unsworth, J., Jimenez-Valverde, A., . . . Hope, W. (2022). Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77(5), 1334-1343. doi:10.1093/jac/dkac038DOI: 10.1093/jac/dkac038
Asiimwe, I., Pushpakom, S., Turner, R., Kolamunnage-Dona, R., Jorgensen, A., & Pirmohamed, M. (2022). Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-analysis of randomized controlled trials. doi:10.22541/au.164431813.39836023/v1DOI: 10.22541/au.164431813.39836023/v1
Islim, A. I., Millward, C. P., Piper, R. J., Fountain, D. M., Mehta, S., Kolamunnage-Dona, R., . . . Jenkinson, M. D. (2022). External validation and recalibration of an incidental meningioma prognostic model - IMPACT: protocol for an international multicentre retrospective cohort study. BMJ OPEN, 12(1). doi:10.1136/bmjopen-2021-052705DOI: 10.1136/bmjopen-2021-052705
2021
Stevens, D., Lane, D. A., Harrison, S. L., Lip, G. Y. H., & Kolamunnage-Dona, R. (2021). Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review. BMC MEDICAL RESEARCH METHODOLOGY, 21(1). doi:10.1186/s12874-021-01472-xDOI: 10.1186/s12874-021-01472-x
Asiimwe, I. G., Pushpakom, S., Turner, R. M., Kolamunnage-Dona, R., Jorgensen, A. L., & Pirmohamed, M. (2021). Cardiovascular drugs and COVID-19 clinical outcomes: A living systematic review and meta-analysis. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87(12), 4534-+. doi:10.1111/bcp.14927DOI: 10.1111/bcp.14927
Stevens, D., Harrison, S. L., Kolamunnage-Dona, R., Lip, G. Y. H., & Lane, D. A. (2021). The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review. EUROPACE, 23(10), 1511-1527. doi:10.1093/europace/euab092DOI: 10.1093/europace/euab092
Stott, K. E., Le, T., Nguyen, T., Whalley, S., Unsworth, J., Ly, V. T., . . . Hope, W. (2021). Population Pharmacokinetics and Pharmacodynamics of Itraconazole for Disseminated Infection Caused by Talaromyces marneffei.. Antimicrobial agents and chemotherapy, 65(11), e0063621. doi:10.1128/aac.00636-21DOI: 10.1128/aac.00636-21
Darlow, C. A., Docobo-Perez, F., Farrington, N., Johnson, A., McEntee, L., Unsworth, J., . . . Hope, W. (2021). Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.. Antimicrobial Agents and Chemotherapy. doi:10.1128/aac.00293-21DOI: 10.1128/aac.00293-21
Wood, A., Denholm, R., Hollings, S., Cooper, J., Ip, S., Walker, V., . . . CVD-COVID-UK consortium. (2021). Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource.. BMJ (Clinical research ed.), 373, n826. doi:10.1136/bmj.n826DOI: 10.1136/bmj.n826
Nielsen, M. J., Baines, P., Jennings, R., Siner, S., Kolamunnage-Dona, R., Newland, P., . . . Carrol, E. D. (2021). Procalcitonin, C-reactive protein, neutrophil gelatinase-associated lipocalin, resistin and the APTT waveform for the early diagnosis of serious bacterial infection and prediction of outcome in critically ill children.. PLoS One, 16(2), e0246027. doi:10.1371/journal.pone.0246027DOI: 10.1371/journal.pone.0246027
Factors associated with morbidity and mortality outcomes following first cranioplasty (Journal article)
Mustafa, M. A., Millward, C. P., Doherty, J., Islim, A. I., Humphries, T., Gillespie, C. S., . . . McMahon, C. J. (2021). Factors associated with morbidity and mortality outcomes following first cranioplasty. Brain and Spine, 1, 100632. doi:10.1016/j.bas.2021.100632DOI: 10.1016/j.bas.2021.100632
2020
Kolamunnage-Dona, R. (2020). Adjustment for the measurement error in evaluating biomarker performances at baseline for future survival outcomes: Time-dependent ROC curve within a joint modelling framework. Research Methods in Medicine & Health Sciences. doi:10.1177/2632084320972257DOI: 10.1177/2632084320972257
Philipson, P., Hickey, G. L., Crowther, M. J., & Kolamunnage-Dona, R. (2020). Faster Monte Carlo estimation of joint models for time-to-event and multivariate longitudinal data. Computational Statistics & Data Analysis, 151, 107010. doi:10.1016/j.csda.2020.107010DOI: 10.1016/j.csda.2020.107010
Pharmacodynamics of the Novel Metallo-beta-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae (Journal article)
Das, S., Johnson, A., McEntee, L., Farrington, N., Kirby, A., Unsworth, J., . . . Hope, W. (2020). Pharmacodynamics of the Novel Metallo-beta-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 64(11). doi:10.1128/AAC.01076-20DOI: 10.1128/AAC.01076-20
Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae. (Journal article)
Das, S., Johnson, A., McEntee, L., Farrington, N., Kirby, A., Unsworth, J., . . . Hope, W. (2020). Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae.. Antimicrob Agents Chemother, 64(11). doi:10.1128/AAC.01076-20DOI: 10.1128/AAC.01076-20
Asiimwe, I. G., Pushpakom, S., Turner, R. M., Kolamunnage-Dona, R., Jorgensen, A., & Pirmohamed, M. (2020). Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. doi:10.1101/2020.10.07.20208918DOI: 10.1101/2020.10.07.20208918
Bustinduy, A. L., Kolamunnage-Dona, R., Mirochnick, M. H., Capparelli, E. V., Tallo, V., Acosta, L. P., . . . Hope, W. W. (2020). Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum. Antimicrobial Agents and Chemotherapy, 64(9). doi:10.1128/AAC.00566-20DOI: 10.1128/AAC.00566-20
AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy (Journal article)
Johnson, P., Berhane, S., de Groot, E., Toyoda, H., Tada, T., Kumada, T., . . . Hughes, D. M. (2020). AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy. Journal of Hepatology, 73, S387-S388. doi:10.1016/s0168-8278(20)31265-4DOI: 10.1016/s0168-8278(20)31265-4
Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma (Journal article)
Johnson, P., Berhane, S., & Kolamunnage-Dona, R. (2020). Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma. Journal of Hepatology, 73, S388. doi:10.1016/s0168-8278(20)31267-8DOI: 10.1016/s0168-8278(20)31267-8
Zhu, W., Ku, J. Y., Zheng, Y., Knox, P. C., Kolamunnage-Dona, R., & Czanner, G. (2020). Spatial Linear Mixed Effects Modelling for OCT Images: SLME Model. JOURNAL OF IMAGING, 6(6). doi:10.3390/jimaging6060044DOI: 10.3390/jimaging6060044
Islim, A. I., Mohan, M., Moon, R. D. C., Rathi, N., Kolamunnage-Dona, R., Crofton, A., . . . Jenkinson, M. D. (2020). Treatment Outcomes of Incidental Intracranial Meningiomas: Results from the IMPACT Cohort. WORLD NEUROSURGERY, 138, E725-E735. doi:10.1016/j.wneu.2020.03.060DOI: 10.1016/j.wneu.2020.03.060
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing <i>Klebsiella pneumoniae</i> (Journal article)
Johnson, A., McEntee, L., Farrington, N., Kolamunnage-Dona, R., Franzoni, S., Vezzelli, A., . . . Hope, W. (2020). Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing <i>Klebsiella pneumoniae</i>. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 64(6). doi:10.1128/AAC.00180-20DOI: 10.1128/AAC.00180-20
Hughes, D. M., Berhane, S., Emily de Groot, C. A., Toyoda, H., Tada, T., Kumada, T., . . . Johnson, P. (2020). Serum Levels of Alpha Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2020.04.084DOI: 10.1016/j.cgh.2020.04.084
Pushpakom, S. P., Kolamunnage-Dona, R., Taylor, C., Foster, T., Spowart, C., Garcia-Finana, M., . . . Pirmohamed, M. (n.d.). TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy. Clinical Infectious Diseases. doi:10.1093/cid/ciz589DOI: 10.1093/cid/ciz589
Bayesian joint modelling of longitudinal and time to event data: a methodological review (Journal article)
Alsefri, M., Sudell, M., García-Fiñana, M., & Kolamunnage-Dona, R. (2020). Bayesian joint modelling of longitudinal and time to event data: a methodological review. BMC Medical Research Methodology.
Clinical studies of incidental intracranial meningiomas-towards high-quality evidence-based practice (Journal article)
Islim, A. I., Millward, C. P., Martin-McGill, K. J., Kolamunnage-Dona, R., Santarius, T., Mathew, R. K., . . . Jenkinson, M. D. (2020). Clinical studies of incidental intracranial meningiomas-towards high-quality evidence-based practice. ACTA NEUROCHIRURGICA, 162(3), 673-674. doi:10.1007/s00701-020-04214-yDOI: 10.1007/s00701-020-04214-y
Islim, A., Kolamunnage-Dona, R., Mohan, M., Moon, R., Crofton, A., Haylock, B., . . . Jenkinson, M. (2020). A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas. Neuro-Oncology, 22(2), 2278-289. doi:10.1093/neuonc/noz160DOI: 10.1093/neuonc/noz160
Johnson, P., Berhane, S., de Groot, E., Toyoda, H., Tada, T., Kumada, T., . . . Hughes, D. M. (2020). AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy. In JOURNAL OF HEPATOLOGY Vol. 73 (pp. S387-S388). Retrieved from https://www.webofscience.com/
Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma (Conference Paper)
Johnson, P., Berhane, S., & Kolamunnage-Dona, R. (2020). Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma. In JOURNAL OF HEPATOLOGY Vol. 73 (pp. S388). Retrieved from https://www.webofscience.com/
Zhu, W., Ku, J. Y., Zheng, Y., Knox, P., Harding, S. P., Kolamunnage-Dona, R., & Czanner, G. (2020). Spatial Modelling of Retinal Thickness in Images from Patients with Diabetic Macular Oedema. In MEDICAL IMAGE UNDERSTANDING AND ANALYSIS, MIUA 2019 Vol. 1065 (pp. 114-126). doi:10.1007/978-3-030-39343-4_10DOI: 10.1007/978-3-030-39343-4_10
Zhu, W., Kolamunnage-Dona, R., Zheng, Y., Harding, S., & Czanner, G. (2020). Spatial and spatio-temporal statistical analyses of retinal images: a review of methods and applications. BMJ OPEN OPHTHALMOLOGY, 5(1). doi:10.1136/bmjophth-2020-000479DOI: 10.1136/bmjophth-2020-000479
2019
Antoniou, M., Kolamunnage-Dona, R., Wason, J., Bathia, R., Billingham, C., Bliss, J. M., . . . Jorgensen, A. L. (2019). Biomarker-guided trials: Challenges in practice. Contemporary Clinical Trials Communications, 16, 100493. doi:10.1016/j.conctc.2019.100493DOI: 10.1016/j.conctc.2019.100493
Kolamunnage-Dona, R. (2019). Estimating treatment effects in the presence of informative missingness. In TRIALS Vol. 20. Retrieved from https://www.webofscience.com/
Cicconi, S., Ghaneh, P., Neoptolemos, J., Kolamunnage-Dona, R., & Jackson, R. (2019). Joint Modelling for longitudinal measures of marker CA19-9 and survival data in patients with pancreatic cancer. In TRIALS Vol. 20. Retrieved from https://www.webofscience.com/
Sudell, M. E., Kolamunnage-Dona, R., & Tudur Smith, C. (2019). Comparing results from one and two stage meta-analytic joint models. Poster session presented at the meeting of RSS 2019. Belfast.
Ramanan, A. V., Dick, A. D., Jones, A. P., Hughes, D. A., McKay, A., Rosala-Halas, A., . . . Grp, S. Y. C. A. M. O. R. E. S. (2019). Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT. HEALTH TECHNOLOGY ASSESSMENT, 23(15), 1-139. doi:10.3310/hta23150DOI: 10.3310/hta23150
OPTIMISING OBSERVATION STRATEGIES FOR INCIDENTALLY DISCOVERED INTRACRANIAL MENINGIOMAS (Conference Paper)
Islim, A. I., Mohan, M., Moon, R. D. C., Mills, S. J., Brodbelt, A. R., Haylock, B. J., . . . Jenkinson, M. D. (2019). OPTIMISING OBSERVATION STRATEGIES FOR INCIDENTALLY DISCOVERED INTRACRANIAL MENINGIOMAS. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 90 (pp. E9-E10). doi:10.1136/jnnp-2019-ABN.29DOI: 10.1136/jnnp-2019-ABN.29
Le, T., Ly, V. T., Thu, N. T. M., Nguyen, A., Thanh, N. T., Vinh Chau, N. V., . . . Hope, W. (2019). Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by Talaromyces marneffei. Antimicrobial Agents and Chemotherapy, 63(2). doi:10.1128/aac.01739-18DOI: 10.1128/aac.01739-18
Pushpakom, S., Kolamunnage-Dona, R., Taylor, C., Foster, T., Spowart, C., Garcia-Finana, M., . . . Pirmohamed, M. (2019). Telmisartan to reduce insulin resistance in HIV-positive individuals on combination antiretroviral therapy: the TAILoR dose-ranging Phase II RCT.DOI: 10.3310/eme06060
2018
Sudell, M. E., Kolamunnage-Dona, R., Gueyffier, F., & Tudur Smith, C. (2018). Investigation of one-stage meta-analysis methods for joint longitudinal and time-to-event data through simulation and real data application. Statistics in Medicine, 38(2), 247-268. doi:10.1002/sim.7961DOI: 10.1002/sim.7961
Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis (vol 62, e02526-17, 2018) (Journal article)
Stott, K. E., Beardsley, J., Whalley, S., Kibengo, F. M., Nguyen, T. H. M., Nguyen, L. N. T., . . . Day, J. (2018). Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis (vol 62, e02526-17, 2018). ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62(12). doi:10.1128/AAC.02249-18DOI: 10.1128/AAC.02249-18
Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis (vol 62, e00885-18, 2018) (Journal article)
Stott, K. E., Beardsley, J., Kolamunnage-Dona, R., Castelazo, A. S., Kibengo, F. M., Nguyen, T. H. M., . . . Hope, W. (2018). Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis (vol 62, e00885-18, 2018). ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62(12). doi:10.1128/AAC.02254-18DOI: 10.1128/AAC.02254-18
MNGI-22. A PROGNOSTIC INDEX TO PREDICT THE RISK OF ACTIVE MONITORING FAILURE FOR INCIDENTALLY-FOUND ASYMPTOMATIC MENINGIOMAS (Journal article)
Islim, A., Mohan, M., Moon, R., Rathi, N., Kolamunnage-Dona, R., Brodbelt, A., . . . Jenkinson, M. (2018). MNGI-22. A PROGNOSTIC INDEX TO PREDICT THE RISK OF ACTIVE MONITORING FAILURE FOR INCIDENTALLY-FOUND ASYMPTOMATIC MENINGIOMAS. Neuro-Oncology, 20(suppl_6), vi153. doi:10.1093/neuonc/noy148.638DOI: 10.1093/neuonc/noy148.638
Hickey, G., Philipson, P., Jorgensen, A., & Kolamunnage-Dona, R. (2018). A comparison of joint models for longitudinal and competing risks data, with application to an epilepsy drug randomized controlled trial. Journal of the Royal Statistical Society Series A: Statistics in Society, 181(04), 1105-1123. doi:10.1111/rssa.12348DOI: 10.1111/rssa.12348
OS4.1 A risk calculator to predict the need for an intervention within a patient’s estimated lifetime for incidentally-found asymptomatic meningiomas (Journal article)
Islim, A. I., Mohan, M., Moon, R., Kolamunnage-Dona, R., Rathi, N., Mills, S. J., . . . Jenkinson, M. D. (2018). OS4.1 A risk calculator to predict the need for an intervention within a patient’s estimated lifetime for incidentally-found asymptomatic meningiomas. Neuro-Oncology, 20(suppl_3), iii222. doi:10.1093/neuonc/noy139.026DOI: 10.1093/neuonc/noy139.026
Stott, K. E., Beardsley, J., Kolamunnage-Dona, R., Santoyo Castelazo, A., Kibengo, F. M., Mai, N. T. H., . . . Hope, W. (2018). Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis. Antimicrobial Agents and Chemotherapy, 62(9). doi:10.1128/aac.00885-18DOI: 10.1128/aac.00885-18
Kolamunnage-Dona, R. (2018). Evaluation of time-dependent diagnostic efficacy of a baseline. In Diagnostic and Prognostic Research 2018 Vol. 2(Suppl 1):12 (pp. 16). Utrecht, The Netherlands.
Stott, K. E., Beardsley, J., Whalley, S., Kibengo, F. M., Mai, N. T. H., Tung, N. L. N., . . . Day, J. (2018). Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis. Antimicrobial agents and chemotherapy, 62(7). doi:10.1128/aac.02526-17DOI: 10.1128/aac.02526-17
Hickey, G. L., Philipson, P., Jorgensen, A., & Kolamunnage-Dona, R. (2018). joineRML: a joint model and software package for time-to-event and multivariate longitudinal outcomes. BMC MEDICAL RESEARCH METHODOLOGY, 18. doi:10.1186/s12874-018-0502-1DOI: 10.1186/s12874-018-0502-1
Kolamunnage-Dona, R., & Williamson, P. R. (2018). Time-dependent efficacy of longitudinal biomarker for clinical endpoint. Statistical Methods in Medical Research, 27(6), 1909-1924. doi:10.1177/0962280216673084DOI: 10.1177/0962280216673084
Sudell, M., Kolamunnage-Dona, R., & Tudur-Smith, C. (2018). Correction to: joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysis. BMC MEDICAL RESEARCH METHODOLOGY, 18. doi:10.1186/s12874-018-0489-7DOI: 10.1186/s12874-018-0489-7
Negri, C. E., Johnson, A., McEntee, L., Box, H., Whalley, S., Schwartz, J. A., . . . Hope, W. W. (2018). Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.. The Journal of infectious diseases, 217(7), 1118-1127. doi:10.1093/infdis/jix479DOI: 10.1093/infdis/jix479
Hickey, G. L., Mokhles, M., Chambers, D., & Kolamunnage-Dona, R. (2018). Statistical primer: performing repeated-measures analysis. Interactive CardioVascular and Thoracic Surgery, 26(4), 539-544. doi:10.1093/icvts/ivy009DOI: 10.1093/icvts/ivy009
Sudell, M., Tudur Smith, C., Gueyffier, F., & Kolamunnage-Dona, R. (2018). Investigation of two stage meta-analysis methods for joint longitudinal and time-to-event data through simulation and real data application. Statistics in Medicine, 37(8), 1227-1244. doi:10.1002/sim.7585DOI: 10.1002/sim.7585
Hickey, G. L., Philipson, P., Jorgensen, A., & Kolamunnage-Dona, R. (2018). Joint models of longitudinal and time-to-event data with more than one event time outcome: a review. The International Journal of Biostatistics, 14(1). doi:10.1515/ijb-2017-0047DOI: 10.1515/ijb-2017-0047
2017
Antoniou, M., Jorgensen, A. L., & Kolamunnage-Dona, R. (2017). Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. JOURNAL OF PERSONALIZED MEDICINE, 7(4). doi:10.3390/jpm7040019DOI: 10.3390/jpm7040019
Hope, W. W., McEntee, L., Livermore, J., Whalley, S., Johnson, A., Farrington, N., . . . Rex, J. H. (n.d.). Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease.. mBio, 8(4). doi:10.1128/mbio.01157-17DOI: 10.1128/mbio.01157-17
Irwin, A. D., Grant, A., Williams, R., Kolamunnage-Dona, R., Drew, R. J., Paulus, S., . . . Carrol, E. D. (2017). Predicting Risk of Serious Bacterial Infections in Febrile Children in the Emergency Department. Pediatrics, 140(2), 0. doi:10.1542/peds.2016-2853DOI: 10.1542/peds.2016-2853
Sudell, M. E., Kolamunnage-Dona, R., & Tudur Smith, C. (2017). Practical methods to pool multi-study joint longitudinal and time to event data. In ISCB 2017. Vigo.
Kovanda, L. L., Kolamunnage-Dona, R., Neely, M., Maertens, J., Misun, L., & Hope, W. (2017). Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response. Clinical Infectious Diseases, 64(11), 1557-1563. doi:10.1093/cid/cix198DOI: 10.1093/cid/cix198
Antoniou, M., Kolamunnage-Dona, R., & Jorgensen, A. L. (2017). Biomarker-guided clinical trial designs: sample size calculations with survival endpoints. In TRIALS Vol. 18. Retrieved from https://www.webofscience.com/
Kolamunnage-Dona, R., Cox, T., & Kamarudin, A. N. (2017). Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Medical Research Methodology, 17. doi:10.1186/s12874-017-0332-6DOI: 10.1186/s12874-017-0332-6
Sudell, M. E., Kolamunnage-Dona, R., & Tudur Smith, C. (2017). Methodology for analysis of joint longitudinal and time-to-event data from multiple studies. In Survival Analysis for Junior Researchers (SAfJR). University of Leicester.
Tandon, A., Rajendran, I., Aziz, M., Kolamunnage-Dona, R., Nunes, Q. M., & Shrotri, M. (2017). Laparoscopy-assisted gastrectomy in the elderly: experience from a UK centre. Annals of the Royal College of Surgeons of England, 99(4), 325-331. doi:10.1308/rcsann.2016.0344DOI: 10.1308/rcsann.2016.0344
Kolamunnage-Dona, R. (2017). Incorporating the time-dependency in ROC methodology for censored clinical event. In Diagnostic and Prognostic Research 2017, 1(Suppl 1):7 (pp. 16). Birmingham, UK.
Methods for Evaluating Medical Tests and Biomarkers (Journal article)
Gopalakrishna, G., Langendam, M., Scholten, R., Bossuyt, P., Leeflang, M., Noel-Storr, A., . . . de Bono, J. (2017). Methods for Evaluating Medical Tests and Biomarkers. Diagnostic and Prognostic Research, 1(S1). doi:10.1186/s41512-016-0001-yDOI: 10.1186/s41512-016-0001-y
Antoniou, M., Kolamunnage-Dona, R., & Jorgensen, A. L. (2017). Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. Journal of Personalized Medicine, 7(1). doi:10.3390/jpm7010001DOI: 10.3390/jpm7010001
2016
Sudell, M. E., Kolamunnage-Dona, R., & Tudur Smith, C. (2016). Joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysis. BMC Medical Research Methodology, 16. doi:10.1186/s12874-016-0272-6DOI: 10.1186/s12874-016-0272-6
A Randomized Controlled Trial of Extended Brief Intervention for Alcohol-Dependent Patients in an Acute Hospital Setting (Journal article)
Owens, L., Kolamunnage-Dona, R., Owens, A., Perkins, E., Butcher, G., Wilson, K., . . . Pirmohamed, M. (2016). A Randomized Controlled Trial of Extended Brief Intervention for Alcohol-Dependent Patients in an Acute Hospital Setting. Alcohol and Alcoholism, 51(05), 584-592. doi:10.1093/alcalc/agw023DOI: 10.1093/alcalc/agw023
Hickey, G. L., Philipson, P., Jorgensen, A., & Kolamunnage-Dona, R. (2016). Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues. BMC Medical Research Methodology, 16. doi:10.1186/s12874-016-0212-5DOI: 10.1186/s12874-016-0212-5
Diabetes mellitus and tobacco smoking independently increase the risk of developing pancreatic cancer in hereditary pancreatitis (HP) in individuals from the European register for hereditary pancreatitis and pancreatic cancer (EUROPAC) (Journal article)
Sheel, A., Costello, E., Neoptolemos, J., Harrison, S., Lerch, M., Mayerle, J., . . . Greenhalf, W. (2016). Diabetes mellitus and tobacco smoking independently increase the risk of developing pancreatic cancer in hereditary pancreatitis (HP) in individuals from the European register for hereditary pancreatitis and pancreatic cancer (EUROPAC). Pancreatology, 16(3), S88. doi:10.1016/j.pan.2016.05.297DOI: 10.1016/j.pan.2016.05.297
A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC) (Journal article)
Owens, L., Butcher, G., Gilmore, I., Kolamunnage-Dona, R., Oyee, J., Perkins, L., . . . Pirmohamed, M. (2011). A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC). BMC Public Health, 11, 528.
Modelling variable dropout in randomised controlled trials with longitudinal outcomes: Application to the MAGNETIC study (Journal article)
Kolamunnage-Dona, R., Powell, C., & Williamson, P. R. (2016). Modelling variable dropout in randomised controlled trials with longitudinal outcomes: Application to the MAGNETIC study. Trials, 17. doi:10.1186/s13063-016-1342-0DOI: 10.1186/s13063-016-1342-0
Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review (Journal article)
Antoniou, M., Jorgensen, A. L., & Kolamunnage-Dona, R. (2016). Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. PLoS One, 11(2). doi:10.1371/journal.pone.0149803DOI: 10.1371/journal.pone.0149803
2015
Pushpakom, S., Taylor, C., Kolamunnage-Dona, R., Spowart, C., Vora, J., Garcia Finana, M., . . . Pirmohamed, M. (2015). Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIVpositive individuals on combination antiretroviral therapy. BMJ Open, 5(10). doi:10.1136/bmjopen-2015-009566DOI: 10.1136/bmjopen-2015-009566
Developing a laboratory-based score to predict mortality in patients admitted to the ICU (Journal article)
Iqbal, A., Welters, I., Kolamunnage-Dona, R., Toh, C., & Downey, C. (n.d.). Developing a laboratory-based score to predict mortality in patients admitted to the ICU. Critical Care, 19(S1). doi:10.1186/cc14627DOI: 10.1186/cc14627
Evaluating statistical characteristics of biomarker-guided trial designs (Journal article)
Antoniou, M., Jorgensen, A., & Kolamunnage-Dona, R. (2015). Evaluating statistical characteristics of biomarker-guided trial designs. TRIALS, 16. doi:10.1186/1745-6215-16-S2-O83DOI: 10.1186/1745-6215-16-S2-O83
2014
Swale, A., Miyajima, F., Kolamunnage-Dona, R., Roberts, P., Little, M., Beeching, N., . . . Pirmohamed, M. (2014). Serum Mannose-Binding Lectin Concentration, but Not Genotype, Is Associated With Clostridium difficile Infection Recurrence: A Prospective Cohort Study. Clinical Infectious Diseases, 59(10), 1429-1436. doi:10.1093/cid/ciu666DOI: 10.1093/cid/ciu666
ECONOMIC EVALUATION OF NEBULIZED MAGNESIUM SULPHATE IN ACUTE SEVERE ASTHMA IN CHILDREN (Journal article)
Petrou, S., Boland, A., Khan, K., Powell, C., Kolamunnage-Dona, R., Lowe, J., . . . Williamson, P. (2014). ECONOMIC EVALUATION OF NEBULIZED MAGNESIUM SULPHATE IN ACUTE SEVERE ASTHMA IN CHILDREN. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 30(4), 354-360. doi:10.1017/S0266462314000440DOI: 10.1017/S0266462314000440
Calprotectin and Lactoferrin Faecal Levels in Patients with Clostridium difficile Infection (CDI): A Prospective Cohort Study (Journal article)
Swale, A., Miyajima, F., Roberts, P., Hall, A., Little, M., Beadsworth, M., . . . Pirmohamed, M. (2014). Calprotectin and Lactoferrin Faecal Levels in Patients with Clostridium difficile Infection (CDI): A Prospective Cohort Study. PLoS One, 9(8). doi:10.1371/journal.pone.0106118DOI: 10.1371/journal.pone.0106118
A review of the handling of missing longitudinal outcome data in clinical trials (Journal article)
Powney, M., Williamson, P., Kirkham, J., & Kolamunnage-Dona, R. (2014). A review of the handling of missing longitudinal outcome data in clinical trials. Trials, 15. doi:10.1186/1745-6215-15-237DOI: 10.1186/1745-6215-15-237
Is the Interleukin 8 Promoter Polymorphism rs4073/–251T >A Associated With Clostridium difficile Infection? (Journal article)
Miyajima, F., Swale, A., Zhang, E., Alfirevic, A., Little, M., Beeching, N., . . . Pirmohamed, M. (2014). Is the Interleukin 8 Promoter Polymorphism rs4073/–251T >A Associated With Clostridium difficile Infection?. Clinical Infectious Disease, 58(12), e148-e151. doi:10.1093/cid/ciu152DOI: 10.1093/cid/ciu152
Lloyd-Williams, M., Payne, S., Reeve, J., & Kolamunnage, D. R. (2014). Thoughts of self-harm and depression as prognostic factors in palliative care patients. Journal Affecitve Disorders, 166, 324-329. doi:10.1016/j.jad.2014.05.029DOI: 10.1016/j.jad.2014.05.029
2013
Adjusting for informative missing outcome data in clinical trials with longitudinal study designs (Journal article)
Kolamunnage-Dona, R., Powel, C., & Williamson, P. (2013). Adjusting for informative missing outcome data in clinical trials with longitudinal study designs. Trials, 14(S1). doi:10.1186/1745-6215-14-s1-p109DOI: 10.1186/1745-6215-14-s1-p109
Antidepressant medication in patients with advanced cancer--an observational study (Journal article)
Lloyd-Williams, M., Payne, S., Reeve, J., & Kolamunnage Dona, R. (2013). Antidepressant medication in patients with advanced cancer--an observational study. QJM, 106(11), 995-1001. doi:10.1093/qjmed/hct133DOI: 10.1093/qjmed/hct133
Sample size formula for joint modelling of longitudinal and time-to-event data in clinical trials (Journal article)
Powney, M., Williamson, P., & Kolamunnage-Dona, R. (2013). Sample size formula for joint modelling of longitudinal and time-to-event data in clinical trials. Trials, 14(S1). doi:10.1186/1745-6215-14-s1-o108DOI: 10.1186/1745-6215-14-s1-o108
Assessment and clinical course of hypocalcemia in critical illness (Journal article)
Steele, T., Kolamunnage-Dona, R., Downey, C., Toh, C. -H., & Welters, I. (2013). Assessment and clinical course of hypocalcemia in critical illness. CRITICAL CARE, 17(3). doi:10.1186/cc12756DOI: 10.1186/cc12756
Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial (Journal article)
Powell, C., Kolamunnage-Dona, R., Lowe, J., Boland, A., Petrou, S., Doull, I., . . . Williamson, P. (2013). Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial. LANCET RESPIRATORY MEDICINE, 1(4), 301-308. doi:10.1016/S2213-2600(13)70037-7DOI: 10.1016/S2213-2600(13)70037-7
Albumin-adjusted calcium concentration should not be used to identify hypocalcaemia in critical illness (Journal article)
Steele, T., Kolamunnage-Dona, R., Downey, C., Toh, C., & Welters, I. (2013). Albumin-adjusted calcium concentration should not be used to identify hypocalcaemia in critical illness. Critical Care, 17(S2). doi:10.1186/cc12384DOI: 10.1186/cc12384
A multistate modelling approach for pancreatic cancer development in genetically high-risk families (Journal article)
Kolamunnage-Dona, R., Vitone, L., Greenhalf, W., Henderson, R., & Williamson, P. R. (2013). A multistate modelling approach for pancreatic cancer development in genetically high-risk families. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 62(2), 201-212. doi:10.1111/j.1467-9876.2012.01051.xDOI: 10.1111/j.1467-9876.2012.01051.x
Albumin-adjusted calcium concentration should not be used to identify hypocalcaemia in critical illness (Conference Paper)
Steele, T., Kolamunnage-Dona, R., Downey, C., Toh, C., & Welters, I. (2013). Albumin-adjusted calcium concentration should not be used to identify hypocalcaemia in critical illness. In Intensive Care and Emergency Medicine (pp. 1). Brussels: ICICEM.
Assessment and clinical course of hypocalcemia in critical illness. (Journal article)
Steele, T., Kolamunnage-Dona, R., Downey, C., Toh, C. H., & Welters, I. (2013). Assessment and clinical course of hypocalcemia in critical illness.. Critical Care, 17(3).
MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo-controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children. (Journal article)
Powell, C. V. E., Kolamunnage-Dona, R., Lowe, J., Boland, A., Petrou, S., Doull, I., . . . MAGNETIC study group. (2013). MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo-controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children.. Health technology assessment (Winchester, England), 17(45), v-216. doi:10.3310/hta17450DOI: 10.3310/hta17450
Time course of hyponatraemia in critical care (Conference Paper)
Nee, A. E., Welters, I. D., Steele, T., & Kolamunnage-Dona, R. (2013). Time course of hyponatraemia in critical care. In European Society of Intensive Care Medicine (pp. 1). 1820 Montreux: ESICM 2013.
2012
Novel biomarker combination improves the diagnosis of serious bacterial infections in Malawian children (Journal article)
Irwin, A. D., Marriage, F., Mankhambo, L. A., Group, I. P. D. S., Jeffers, G., Kolamunnage-Dona, R., . . . Carrol, E. D. (2012). Novel biomarker combination improves the diagnosis of serious bacterial infections in Malawian children. BMC Medical Genomics, 5(1). doi:10.1186/1755-8794-5-13DOI: 10.1186/1755-8794-5-13
MAGNESIUM TRIAL IN CHILDREN (MAGNETIC): A Randomised, Placebo Controlled Trial of Nebulised Magnesium Sulphate in Acute Severe Asthma in Children (Journal article)
Powell, C. V. E., Kolamunnage-Dona, R., Lowe, J., Boland, A., Petrou, S., Doull, I., . . . on behalf of the MAGNETIC study group. (2012). MAGNESIUM TRIAL IN CHILDREN (MAGNETIC): A Randomised, Placebo Controlled Trial of Nebulised Magnesium Sulphate in Acute Severe Asthma in Children. Health Technology Assessment.
joineR: Joint modelling of repeated measurements and time-to-event data. (Software / Code)
Philipson, P., Sousa, I., Diggle, P., Williamson, P., Kolamunnage-Dona, R., & Henderson, R. (2012). joineR: Joint modelling of repeated measurements and time-to-event data. (Version 1) [Internet (free access)]. Comprehensive R Archive Network, United Kingdom.. Retrieved from http://cran.r-project.org/web/packages/joineR/index.html
2011
A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC) (Journal article)
Owens, L., Butcher, G., Gilmore, I., Kolamunnage-Dona, R., Oyee, J., Perkins, L., . . . Pirmohamed, M. (2011). A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC). BMC PUBLIC HEALTH, 11. doi:10.1186/1471-2458-11-528DOI: 10.1186/1471-2458-11-528
Brief Interventions in Dependent Drinkers: A Comparative Prospective Analysis in Two Hospitals (Journal article)
Cobain, K., Owens, L., Kolamunnage-Dona, R., Fitzgerald, R., Gilmore, I., & Pirmohamed, M. (2011). Brief Interventions in Dependent Drinkers: A Comparative Prospective Analysis in Two Hospitals. ALCOHOL AND ALCOHOLISM, 46(4), 434-440. doi:10.1093/alcalc/agr044DOI: 10.1093/alcalc/agr044
Depressive and manic symptoms are not opposite poles in bipolar disorder (Journal article)
Johnson, S. L., Morriss, R., Scott, J., Paykel, E., Kinderman, P., Kolamunnage-Dona, R., & Bentall, R. P. (2011). Depressive and manic symptoms are not opposite poles in bipolar disorder. ACTA PSYCHIATRICA SCANDINAVICA, 123(3), 206-210. doi:10.1111/j.1600-0447.2010.01602.xDOI: 10.1111/j.1600-0447.2010.01602.x
Investigating the effect of differential titration rates on efficacy and tolerability between new and standard drugs (Conference Paper)
Kolamunnage-Dona, R., Williamson, P., Philipson, P., & Marson, A. (2011). Investigating the effect of differential titration rates on efficacy and tolerability between new and standard drugs. In MRC North West Hub for Trials Methodology Research Showcase Meeting (pp. 1). Liverpool: MRC HUB.
Joint modelling of longitudinal and competing risks data (Conference Paper)
Kolamunnage-Dona, R., Williamson, P., Philipson, P., & Marson, A. (2011). Joint modelling of longitudinal and competing risks data. In IBS Channel Network Conference (pp. 1). Bordeaux: IBS Channel Network Conference.
Longitudinal and event time data: Medical section meeting. (Journal article)
Kolamaunnage-Doan, R. (2011). Longitudinal and event time data: Medical section meeting.. RSS NEWS, 39(4), 14.
2010
Assessing the potential for outcome reporting bias in a review: a tutorial (Journal article)
Dwan, K., Gamble, C., Kolamunnage-Dona, R., Mohammed, S., Powell, C., & Williamson, P. R. (2010). Assessing the potential for outcome reporting bias in a review: a tutorial. TRIALS, 11. doi:10.1186/1745-6215-11-52DOI: 10.1186/1745-6215-11-52
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention (Journal article)
Greenhalgh, J., Bagust, A., Boland, A., Saborido, C. M., Fleeman, N., McLeod, C., . . . Fisher, M. (n.d.). Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention. Health Technology Assessment, 14(Suppl 1), 31-38. doi:10.3310/hta14suppl1-05DOI: 10.3310/hta14suppl1-05
Patients with epilepsy: Cognitively compromised before the start of antiepileptic drug treatment? (Journal article)
Taylor, J., Kolamunnage-Dona, R., Marson, A. G., Smith, P. E. M., Aldenkamp, A. P., & Baker, G. A. (2010). Patients with epilepsy: Cognitively compromised before the start of antiepileptic drug treatment?. EPILEPSIA, 51(1), 48-56. doi:10.1111/j.1528-1167.2009.02195.xDOI: 10.1111/j.1528-1167.2009.02195.x
Enhanced relapse prevention for bipolar disorder by community mental health teams: cluster feasibility randomised trial (Journal article)
Lobban, F., Taylor, L., Chandler, C., Tyler, E., Kinderman, P., Kolamunnage-Dona, R., . . . Morriss, R. K. (2010). Enhanced relapse prevention for bipolar disorder by community mental health teams: cluster feasibility randomised trial. BRITISH JOURNAL OF PSYCHIATRY, 196(1), 59-63. doi:10.1192/bjp.bp.109.065524DOI: 10.1192/bjp.bp.109.065524
Evaluation of Longitudinal Biomarkers (Conference Paper)
Kolamunnage-Dona, R., Williamson, P., Toh, C. H., Welters, I., & Downey, C. (2010). Evaluation of Longitudinal Biomarkers. In METHODS FOR EVALUATING MEDICAL TESTS AND BIOMARKERS: 2010 Symposium (pp. 37). Birmingham: University of Birmingham.
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention (Journal article)
Greenhalgh, J., Bagust, A., Boland, A., Saborido, C. M., Fleeman, N., McLeod, C., . . . Fisher, M. (n.d.). Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention. Health Technology Assessment, 14(Suppl 1). doi:10.3310/hta14suppl1/05DOI: 10.3310/hta14suppl1/05
SANAD study group. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment? (Journal article)
Taylor, J., Kolamunnage-Dona, R., Marson, A. G., Smith, P. E., Aldenkamp, A. P., & Baker, G. A. (2010). SANAD study group. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?. Epilepsia, 51(1), 48-56.
2008
Joint modelling of longitudinal and competing risks data (Journal article)
Williamson, P. R., Kolamunnage-Dona, R., Philipson, R., & Marson, A. G. (2008). Joint modelling of longitudinal and competing risks data. STATISTICS IN MEDICINE, 27(30), 6426-6438. doi:10.1002/sim.3451DOI: 10.1002/sim.3451
2007
The influence of competing-risks setting on the choice of hypothesis test for treatment effect (Journal article)
Williamson, P. R., Kolamunnage-Dona, R., & Smith, C. T. (2007). The influence of competing-risks setting on the choice of hypothesis test for treatment effect. BIOSTATISTICS, 8(4), 689-694. Retrieved from https://www.webofscience.com/
Joint modelling of competing risks in anti-epileptic drug trials and quality of life in epilepsy (Conference Paper)
Kolamunnage-Dona, R., Williamson, P. R., Gamble, C., Phillipson, P., Jacoby, A., & Marson, A. (2007). Joint modelling of competing risks in anti-epileptic drug trials and quality of life in epilepsy. In 28th Annual Conference of the International Society for Clinical Biostatistics (pp. 89). Greece: ISCB.
Modelling the association between diabetes onset and pancreatic cancer allowing for the competing risks of resection (Conference Paper)
Kolamunnage-Dona, R., Williamson, P. R., Henderson, R., & Vitone, L. (2007). Modelling the association between diabetes onset and pancreatic cancer allowing for the competing risks of resection. In 28th Annual Conference of the International Society for Clinical Biostatistics (pp. 189). Greece: ISCB.
2005
Analysing shape variation of biological objects (Thesis / Dissertation)
Kolamunnage-Dona, R. (2005). Analysing shape variation of biological objects. (PhD Thesis, University of Leeds).
Decomposing departures from bilateral symmetry (Chapter)
Kolamunnage-Dona, R., & Kent, J. T. (2005). Decomposing departures from bilateral symmetry. In S. Barber, P. D. Baxter, K. V. Mardia, & R. E. Walls (Eds.), Quantitative Biology, Shape Analysis and Wavelets (pp. 75-78). Leeds: Leeds University Press.
Visualising facial asymmetry (Conference Paper)
Kolamunnage-Dona, R. (2005). Visualising facial asymmetry. In Research Students Conference in Probability and Statistics (pp. 62). Cambridge: RSC.
2004
Symmetric and Asymmetric variation of Shape (Conference Paper)
Kolamunnage-Dona, R. (2004). Symmetric and Asymmetric variation of Shape. In International Sri Lankan Statistical Conference (pp. 253). Kandy: ISSC.
2003
PCA for Shape Variation about an Underlying Symmetric Shape (Chapter)
Kolamunnage-Dona, R., & Kent, J. T. (2003). PCA for Shape Variation about an Underlying Symmetric Shape. In R. G. Aykroyd, K. V. Mardia, & M. J. Langdon (Eds.), Stochastic Geometry, Biological Structure and Images (pp. 137-139). Leeds: Leeds University Press.
2002
Type I Progressively Censored variables-Sampling Plans in the Presence of Competing Risks (Thesis / Dissertation)
Kolamunnage-Dona, R. (2002). Type I Progressively Censored variables-Sampling Plans in the Presence of Competing Risks. (Master's Thesis, National University of Singapore).